Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study

Henk  Lokhorst; Torben Plesner; Peter Gimsing; Hareth Nahi; Monique Minnema; Ulrik Niels Lassen; Jakub Krejcik; Jacob  Laubach; Steen Lisby; Linda  Basse; Paul Richardson

Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study

Henk Lokhorst, Torben Plesner, Peter Gimsing, Hareth Nahi, Monique Minnema, Ulrik Niels Lassen, Jakub Krejcik, Jacob Laubach, Steen Lisby, Linda Basse, Paul Richardson

Aarhus Universitetshospital

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	maj 2013
Status	Udgivet - maj 2013
Begivenhed	Annual Meeting of the American Society of Clinical Oncology - Chicago, USA Varighed: 31. maj 2013 → 4. jun. 2013

Konference

Konference	Annual Meeting of the American Society of Clinical Oncology
Land/Område	USA
By	Chicago
Periode	31/05/2013 → 04/06/2013

Citationsformater

Lokhorst, H., Plesner, T., Gimsing, P., Nahi, H., Minnema, M., Lassen, U. N., Krejcik, J., Laubach, J., Lisby, S., Basse, L., & Richardson, P. (2013). Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study. Abstract fra Annual Meeting of the American Society of Clinical Oncology, Chicago, USA.

@conference{ba4e1459eee445219b0c2486160fcfab,

title = "Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study",

author = "Henk Lokhorst and Torben Plesner and Peter Gimsing and Hareth Nahi and Monique Minnema and Lassen, {Ulrik Niels} and Jakub Krejcik and Jacob Laubach and Steen Lisby and Linda Basse and Paul Richardson",

year = "2013",

month = may,

language = "English",

note = "Annual Meeting of the American Society of Clinical Oncology ; Conference date: 31-05-2013 Through 04-06-2013",

}

Lokhorst, H, Plesner, T, Gimsing, P, Nahi, H, Minnema, M, Lassen, UN, Krejcik, J, Laubach, J, Lisby, S, Basse, L & Richardson, P 2013, 'Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study', Annual Meeting of the American Society of Clinical Oncology, Chicago, USA, 31/05/2013 - 04/06/2013.

Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study. / Lokhorst, Henk ; Plesner, Torben; Gimsing, Peter et al.
2013. Abstract fra Annual Meeting of the American Society of Clinical Oncology, Chicago, USA.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

TY - ABST

T1 - Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study

AU - Lokhorst, Henk

AU - Plesner, Torben

AU - Gimsing, Peter

AU - Nahi, Hareth

AU - Minnema, Monique

AU - Lassen, Ulrik Niels

AU - Krejcik, Jakub

AU - Laubach, Jacob

AU - Lisby, Steen

AU - Basse, Linda

AU - Richardson, Paul

PY - 2013/5

Y1 - 2013/5

M3 - Conference abstract for conference

T2 - Annual Meeting of the American Society of Clinical Oncology

Y2 - 31 May 2013 through 4 June 2013

ER -